Association of Mobile-Enhanced Remote Patient Monitoring with Blood Pressure Control in Hypertensive Patients with Comorbidities: A Multicenter Pre-Post Evaluation
Ullah et al.
The finding, in our words
Implementation of a mobile-enhanced remote patient monitoring programme for hypertensive patients with comorbidities was associated with a substantial improvement in blood pressure control (from 62.4% to 90.1%) and concurrent intensification of guideline-concordant therapy. The findings support the potential of decentralised monitoring to improve clinical outcomes, though the lack of a concurrent control group limits causal interpretation.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
This proof-of-concept study demonstrated that patients with inflammatory bowel disease could successfully perform capillary blood microsampling at home with high analytical success rates, and a majority preferred this decentralised approach over hospital venous draws.
Schuurman et al., Inflammatory bowel diseases · source ↗
In a 20-person proof-of-concept pilot among veterans with HIV, remote self-collection of dried blood spots for phosphatidylethanol monitoring was feasible and acceptable, with high return and analysis rates and positive feedback; a small first step toward decentralised alcohol biomarker monitoring rather than proof of it.
Sheinfil et al., Journal of substance use and addiction treatment (paywalled) · source ↗
The High-Definition Oncology feasibility study in 30 women with metastatic cancer demonstrated high adherence to biospecimen collection (97.4% plasma, 80.7% stool) and wearable monitoring (70–95% of days captured for activity, heart rate, sleep, and oxygen saturation). This establishes a viable framework for decentralised, multimodal data collection in oncology to support individualised treatment models.
Garma et al., JCO precision oncology (paywalled) · source ↗
The GOLD pathway using home capillary blood glucose monitoring proved feasible and safe in 126 older adults with cancer on steroid therapy, with diabetes medication intervention needed in 32% but only two diabetes-related hospitalisations and three asymptomatic hypoglycaemic events, suggesting effective hyperglycaemia management without excess risk.
Liuu et al., European geriatric medicine (paywalled) · source ↗
This study validated a method combining quantitative dried blood spots with DNA methylation analysis to monitor B-cell counts remotely, achieving 100% sensitivity and specificity for a specific clinical threshold. This decentralised approach facilitates patient-centric therapeutic drug monitoring for anti-CD20 therapies by overcoming the logistical barriers of regular venous sampling.
Tallantyre et al., Multiple sclerosis (paywalled) · source ↗